We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.27B
AUM Growth
+$187M
Cap. Flow
-$201M
Cap. Flow %
-2.17%
Top 10 Hldgs %
8.81%
Holding
1,234
New
57
Increased
340
Reduced
328
Closed
245

Top Buys

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$18.1M
2
PLMR icon
Palomar
PLMR
+$13.4M
3
GCMG icon
GCM Grosvenor
GCMG
+$12.9M
4
ACA icon
Arcosa
ACA
+$11.8M
5
MIDD icon
Middleby
MIDD
+$10.2M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 21.11%
3 Financials 13.34%
4 Consumer Discretionary 12.55%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRNA
1201
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-1,854
Closed -$47K
XEC
1202
DELISTED
CIMAREX ENERGY CO
XEC
-6,200
Closed -$170K
WRI
1203
DELISTED
Weingarten Realty Investors
WRI
-67
Closed -$1K
MSGN
1204
DELISTED
MSG Networks Inc.
MSGN
-3,648
Closed -$36K
NAV
1205
DELISTED
Navistar International
NAV
-2,334
Closed -$66K
GLOG
1206
DELISTED
GASLOG LTD
GLOG
-383,900
Closed -$1.08M
GNMK
1207
DELISTED
GenMark Diagnostics, Inc
GNMK
-12,000
Closed -$177K
EGOV
1208
DELISTED
NIC Inc
EGOV
-1,890
Closed -$43K
IPHI
1209
DELISTED
INPHI CORPORATION
IPHI
-23,000
Closed -$2.7M
OCSI
1210
DELISTED
Oaktree Strategic Income Corporation
OCSI
-4,133
Closed -$26K
OXFD
1211
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-5,200
Closed -$68K
EV
1212
DELISTED
Eaton Vance Corp.
EV
-35
Closed -$1K
TNAV
1213
DELISTED
Telenav Inc.
TNAV
-5,072
Closed -$28K
NGHC
1214
DELISTED
National General Holdings Corp
NGHC
-3,321
Closed -$72K
DNKN
1215
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-76,000
Closed -$4.96M
HUD
1216
DELISTED
Hudson Ltd. Class A Common Shares
HUD
-518,466
Closed -$2.52M
AMAG
1217
DELISTED
AMAG Pharmaceuticals
AMAG
-7,412
Closed -$57K
RST
1218
DELISTED
ROSETTA STONE INC
RST
-37,000
Closed -$624K
AKCA
1219
DELISTED
Akcea Therapeutics Inc
AKCA
-2,152
Closed -$29K
PFNX
1220
DELISTED
Pfenex Inc.
PFNX
-203,087
Closed -$1.7M
SHLO
1221
DELISTED
Shiloh Industries Inc
SHLO
-269,717
Closed -$437K
GSB
1222
DELISTED
GlobalSCAPE, Inc.
GSB
-3,891
Closed -$38K
BFYT
1223
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
-47,800
Closed -$978K
FSB
1224
DELISTED
Franklin Financial Network, Inc.
FSB
-115,540
Closed -$2.98M
ENT
1225
DELISTED
Global Eagle Entertainment Inc.
ENT
-4,400
Closed -$21K

Similar funds

Royce & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Royce & Associates held 1,234 positions worth $9.27B, up 2.1% from $9.08B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q3 2020 filing shows 57 new, 340 increased, 328 reduced and 245 closed positions. Its largest new stake was Palomar: 136,247 shares worth $14.2M. The largest sale was Ares Management, an estimated $36.8M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2020 buy was Palomar: 136,247 shares worth $14.2M.
  • Royce & Associates added most to John B. Sanfilippo & Son in Q3 2020, an estimated $18.1M increase.
  • Royce & Associates's biggest Q3 2020 reduction was Ares Management, cutting an estimated $36.8M.
  • Royce & Associates fully exited Children's Place in Q3 2020, selling an estimated $11.2M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.27B portfolio in Q3 2020.
  • Royce & Associates opened 57 new positions and closed 245 in Q3 2020.
  • Royce & Associates's portfolio value rose 2.1% quarter-over-quarter to $9.27B.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.